NCT02965911.

Trial name or title	A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined with Ursodeoxycholic Acid in PBC Patients with an Incomplete Biochemical Response to UDCA
Methods	Open‐label, randomised clinical trial.
Participants	People with primary biliary cholangitis.
Interventions	Group 1: fenofibrate + UDCA. Further details: UDCA 13 mg/kg/day to 15 mg/kg/day + fenofibrate 200 mg once daily for 12 months. Group 2: UDCA. Further details: UDCA 13 mg/kg/day to 15 mg/kg/day.
Outcomes	None of the outcomes of interest for this review measured in this trial.
Starting date	January 2016.
Contact information	zszou302@163.com
Notes	Status: recruiting.

UDCA: ursodeoxycholic acid.